Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-035609

Adamas Pharmaceuticals Inc · ADMS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gregory T Went
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 20, 2015M2,610$1.875A22,618D
Common StockF2,F1Apr 20, 2015S2,610$18.0002D20,008D
Common StockF2,F1Apr 20, 2015S5,200$18.0002D397,103IGregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common StockF1Apr 21, 2015M962$1.875A20,970D
Common StockF3,F1Apr 21, 2015S962$18.0064D20,008D
Common StockF3,F1Apr 21, 2015S1,811$18.0024D395,292IGregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common Stockholding———6,666IGregory T Went Cust - Bridget Went Under CA Uniform Transfers to Minors Act
Common Stockholding———6,666IGregory T Went Cust - Cora Went Under CA Uniform Transfers to Minors Act
Common Stockholding———80,000IGregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Bridget Elise Went
Common Stockholding———80,000IGregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Cora Margaret Went

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4$1.875Apr 20, 2015M2,610D—Sep 12, 2016Common Stock2,610227,390D
Stock Option (Right to Buy)F4$1.875Apr 21, 2015M962D—Sep 12, 2016Common Stock962226,428D

Explanation of responses